Catheter Precision Expands Market Reach with Croatia Order
Catheter Precision Celebrates a Significant Milestone
Catheter Precision, Inc. (VTAK - NYSE/American), a forefront player in the medical device sector focused on cardiac electrophysiology, has made headlines with its groundbreaking first purchase order from a Croatian hospital. This exciting news marks a pivotal moment in the company’s journey, showcasing its commitment to advancing healthcare globally.
Winning the Competitive Tender
The announcement follows the successful completion of a thorough evaluation by Dubrava Hospital, a noted institution in Croatia. The hospital's competitive bidding process highlighted the efficacy and innovation of Catheter Precision’s technology, specifically their VIVO system. Dr. Ivan Zeljkovic, who heads the Electrophysiology Lab at Dubrava University Hospital, expressed high praise for the VIVO system, stating, "The VIVO workflow is not only simple but flexible. The accuracy of our VIVO maps went beyond my expectations, allowing us to identify the anatomical origins of ventricular arrhythmias with precision.”
Dubrava Hospital: A Leader in Healthcare
Dubrava University Hospital, located in Croatia's capital, Zagreb, stands out as a prominent medical facility, managing over 25,000 inpatients yearly and delivering extensive outpatient services to more than 400,000 individuals. Beyond its role as a teaching hospital, Dubrava is crucial in driving research initiatives, making it a perfect partner for innovative medical technologies.
Enhancing Patient Care Across Europe
Fatih Ayoglu, Sales Manager for EMEA & APAC at Catheter Precision, emphasized the significance of this milestone: “It goes beyond mere geographical expansion. This achievement illustrates the trust that esteemed healthcare professionals and partners across Europe have in our technology. We are excited to work alongside such visionary practitioners who are committed to elevating patient care.”
Introducing the VIVO System
The VIVO system, which stands for View Into Ventricular Onset, offers a non-invasive 3D imaging solution. This innovative tool empowers healthcare providers by identifying the sources of ventricular arrhythmias prior to procedures. This capability not only streamlines workflow but also significantly reduces the duration of medical procedures. VIVO has garnered marketing authorization from the U.S. FDA, as well as the prestigious CE Mark, recognizing its safety and effectiveness for use in Europe.
Innovative Solutions from Catheter Precision
Catheter Precision is committed to revolutionizing the way cardiac arrhythmias are treated. By focusing on groundbreaking technologies and fostering partnerships with healthcare professionals, the company is at the forefront of transforming electrophysiology procedures. Their continuous efforts to innovate keep them ahead of the curve, ensuring they meet the evolving needs of the medical community.
Conclusion: A Bright Future Ahead
This inaugural purchase order in Croatia sets the stage for Catheter Precision’s expansion into the European market. With their innovative approach and commitment to enhancing patient care, the company is positioned for continued growth and success. As they look ahead, one can only anticipate the positive impact they will have on medical treatments and patient outcomes in the region.
Frequently Asked Questions
What is the significance of Catheter Precision's first purchase order in Croatia?
This purchase order marks a major milestone for Catheter Precision, showcasing their growing influence in the European healthcare market.
What is the VIVO system?
The VIVO system is a cutting-edge, non-invasive 3D imaging solution designed to help physicians identify the origins of ventricular arrhythmias before procedures, thus improving efficiency.
Who is Dr. Ivan Zeljkovic?
Dr. Ivan Zeljkovic is the Head of the Electrophysiology Lab at Dubrava University Hospital and has praised the capabilities and accuracy of the VIVO system.
How does Dubrava Hospital rank in the healthcare system?
Dubrava Hospital is one of Croatia's leading healthcare facilities, known for treating a high volume of patients and providing comprehensive medical services.
What are the next steps for Catheter Precision following this milestone?
Following this purchase order, Catheter Precision aims to further expand its presence in Europe while continuing to enhance their technology and foster relationships with healthcare professionals.
About The Author
Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.